John G. Ullman & Associates’s Dentsply Sirona XRAY Stock Holding History

John G. Ullman & Associates’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$269K	Buy	+23,200	New	+$289K	0.04%	158
2025 Q4	–	Sell	-23,700	Closed	-$301K	–	184
2025 Q3	$301K	Buy	23,700 +7,900	+50%	+$115K	0.04%	151
2025 Q2	$251K	Sell	15,800 -9,700	-38%	-$145K	0.04%	154
2025 Q1	$381K	Sell	25,500 -4,300	-14%	-$76.2K	0.06%	142
2024 Q4	$566K	Sell	29,800 -163,206	-85%	-$3.45M	0.08%	122
2024 Q3	$5.22M	Buy	193,006 +109,083	+130%	+$2.79M	0.75%	44
2024 Q2	$2.09M	Sell	83,923 -86,922	-51%	-$2.49M	0.32%	84
2024 Q1	$5.67M	Buy	170,845 +41,115	+32%	+$1.4M	0.87%	37
2023 Q4	$4.62M	Buy	129,730 +10,400	+9%	+$330K	0.73%	44
2023 Q3	$4.08M	Sell	119,330 -2,780	-2%	-$106K	0.67%	47
2023 Q2	$4.89M	Sell	122,110 -3,350	-3%	-$133K	0.75%	43
2023 Q1	$4.93M	Sell	125,460 -5,050	-4%	-$185K	0.77%	45
2022 Q4	$4.16M	Buy	130,510 +1,055	+0.8%	+$31.8K	0.66%	45
2022 Q3	$3.67M	Sell	129,455 -65,661	-34%	-$2.24M	0.64%	45
2022 Q2	$6.97M	Sell	195,116 -58,722	-23%	-$2.37M	1.12%	28
2022 Q1	$12.5M	Buy	253,838 +19,105	+8%	+$1.01M	1.73%	17
2021 Q4	$13.1M	Buy	234,733 +18,200	+8%	+$1M	1.8%	16
2021 Q3	$12.6M	Sell	216,533 -1,609	-0.7%	-$99.2K	1.71%	22
2021 Q2	$13.8M	Sell	218,142 -45,316	-17%	-$2.98M	1.8%	22
2021 Q1	$16.8M	Sell	263,458 -5,050	-2%	-$293K	2.26%	14
2020 Q4	$14.1M	Sell	268,508 -1,975	-0.7%	-$97.4K	2.18%	16
2020 Q3	$11.8M	Buy	270,483 +44,133	+19%	+$1.95M	2.45%	13
2020 Q2	$9.97M	Buy	226,350 +15,350	+7%	+$649K	2.43%	16
2020 Q1	$8.19M	Sell	211,000 -1,900	-0.9%	-$96.8K	2.17%	13
2019 Q4	$12M	Sell	212,900 -4,050	-2%	-$226K	2.07%	12
2019 Q3	$11.6M	Sell	216,950 -3,650	-2%	-$196K	2.1%	15
2019 Q2	$12.9M	Sell	220,600 -3,075	-1%	-$165K	2.26%	10
2019 Q1	$11.1M	Sell	223,675 -1,825	-0.8%	-$80.4K	2.01%	15
2018 Q4	$8.39M	Buy	225,500 +84,000	+59%	+$3.06M	1.69%	22
2018 Q3	$5.34M	Buy	+141,500	New	+$5.89M	0.97%	33
2017 Q2	–	Sell	-47,423	Closed	-$2.96M	–	119
2017 Q1	$2.96M	Sell	47,423 -300	-0.6%	-$18.1K	0.61%	52
2016 Q4	$2.75M	Sell	47,723 -400	-0.8%	-$23.6K	0.58%	57
2016 Q3	$2.86M	Sell	48,123 -2,700	-5%	-$166K	0.59%	58
2016 Q2	$3.15M	Sell	50,823 -777	-2%	-$47.8K	0.65%	52
2016 Q1	$3.18M	Sell	51,600 -2,950	-5%	-$174K	0.75%	44
2015 Q4	$3.32M	Sell	54,550 -725	-1%	-$43.1K	0.73%	43
2015 Q3	$2.79M	Sell	55,275 -2,830	-5%	-$151K	0.66%	46
2015 Q2	$3M	Sell	58,105 -3,345	-5%	-$173K	0.56%	56
2015 Q1	$3.13M	Sell	61,450 -2,325	-4%	-$120K	0.59%	53
2014 Q4	$3.4M	Sell	63,775 -2,900	-4%	-$148K	0.64%	48
2014 Q3	$3.04M	Sell	66,675 -3,245	-5%	-$153K	0.58%	54
2014 Q2	$3.31M	Sell	69,920 -3,350	-5%	-$156K	0.6%	48
2014 Q1	$3.37M	Sell	73,270 -3,780	-5%	-$175K	0.62%	46
2013 Q4	$3.73M	Sell	77,050 -4,190	-5%	-$196K	0.71%	42
2013 Q3	$3.53M	Sell	81,240 -6,660	-8%	-$284K	0.72%	43
2013 Q2	$3.6M	Buy	+87,900	New	+$3.66M	0.75%	42

Other funds holding XRAY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

John G. Ullman & Associates's XRAY Position: Q1 2026 in Review

John G. Ullman & Associates opened a new position in Dentsply Sirona (XRAY) in Q1 2026: 23,200 shares worth $269K. The stake represents 0.04% of the portfolio and ranks #158 among its holdings. This is a return to the name: John G. Ullman & Associates previously reported a position in XRAY as recently as Q3 2025.

John G. Ullman & Associates first reported a position in XRAY in Q2 2013 and has held it in 46 quarters since. The position peaked at $16.8M in Q1 2021. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

John G. Ullman & Associates held 23,200 shares of Dentsply Sirona worth $269K as of Q1 2026.
Dentsply Sirona was a new John G. Ullman & Associates position in Q1 2026.
Dentsply Sirona made up 0.04% of John G. Ullman & Associates's portfolio in Q1 2026, its #158 holding.
John G. Ullman & Associates first reported a position in Dentsply Sirona in Q2 2013 and has held it in 46 quarters since.
John G. Ullman & Associates's Dentsply Sirona position peaked at $16.8M in Q1 2021.
382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on John G. Ullman & Associates's 13F filing for Q1 2026, filed 6 May 2026.